Blood and Cancer Institute’s Post

🎓 Session 3: "Current Practice of Management of SSc-ILD" focuses on the practical aspects of managing systemic sclerosis interstitial lung disease. We’ll examine real-world case studies 📚, discuss approaches to newly diagnosed and progressive SSc-ILD 🩺, and delve into the complex management of SSc-ILD with pulmonary arterial hypertension (PAH) 💔. 👨🏫 The session will be skillfully chaired by Sidiropoulos, Dimitroulas, and Katsiari, featuring insightful contributions from speakers Theodora Simopoulou, Ilias Dimeas, Vasiliki Kalliopi Bournia, Andriana Papaioannou, @Argyro Repa, and Eirini Vasarmidi #SScILD #ILD #SystemicSclerosis #WorldSclerodermaFoundation #Rheumatology #GreekRheumatology 

Answer: Total Cholesterol Level is not included in the GRACE score. Why: The components of the GRACE Score include: Age Heart rate Systolic blood pressure Serum creatinine level Killip class (heart failure severity) Cardiac arrest at admission ST-segment deviation Elevated cardiac biomarkers The GRACE score is a widely used tool to assess the risk of mortality in patients with acute coronary syndrome (ACS), including both STEMI and NSTEMI. #DailyMCQ #Activelearning #MedicalEducation #LifelongLearning #Futuredoctor #Residency

#Pentraxin-3 (PTX-3), a long pentraxin released from #endothelial cells in response to #inflammatory stimuli, is an promising accurate #biomarker of pulmonary hypertension (PH) risk in subjects with #systemic #sclerosis (SSc), with the lowest values of PTX-3 in subjects at low risk for PH. PTX-3 also differentiated subjects with SSc with PH due to disease of the left side of the heart from those with PH related to pulmonary arterial hypertension or interstitial #lung disease. 🔗https://lnkd.in/dc45JC5G

Sickle Cell has always been a neglected disease in India. It is important to spread awareness about the disease and its treatment. Traditional treatments such as blood transfusion, hydroxyurea, and other medicines have primarily focused on managing symptoms and preventing complications, but recent advancements in medical technology have led to the development of several promising new therapies. These therapies aim not only to manage symptoms but also to address the underlying genetic cause of the disease. Read today's Pioneer to know more #SickleCellWarriors #GeneTherapy #InnovationInHealthcare #sicklecellanemia Indraprastha Apollo Hospitals , New Delhi

A 35-year-old male patient was admitted due to massive hemoptysis that had been going on for three days. Approximately 200 cc of hemoptysis not resulting in asphyxia was identified. He also reported that he had been experiencing coughing and left-side chest pain for four to five months. Physical examination findings were normal. Patient’s history revealed that acute tubular necrosis had developed after six months of tuberculosis treatment, followed by the onset of chronic kidney failure. The patient stated that he had been receiving hemodialysis treatment for two years. Considering the possibility of (...), the patient was admitted to the intensive care unit for follow-up. ❓ What is the diagnosis? 🔎 Let us know what you think and check out this link to find out the answer! https://lnkd.in/dk9QE8rk #science #scientific #journal #medicalstudent

Japanese knotweed contains a high level of resveratrol This herb treats Lyme disease, improves heart function, relieves GI issues, improves cognitive function, reduces cancer risk, improves insulin sensitivity, etc. More natural remedies for chronic Lyme disease: https://lnkd.in/gnniUkky 💕 #lymedisease #resveratrol

Japanese knotweed contains a high level of resveratrol This herb treats Lyme disease, improves heart function, relieves GI issues, improves cognitive function, reduces cancer risk, improves insulin sensitivity, etc. More natural remedies for chronic Lyme disease: https://lnkd.in/g7QMe97a 💕 #lymedisease #resveratrol

Selexipag shows promise for treating pulmonary arterial hypertension associated with connective tissue disease (CTD). The ongoing EXPOSURE (EUPAS19085) study sheds light on the real-world management of PAH-CTD patients in Europe and Canada. Authors: Sean Gaine, Pilar Escribano, Audrey Muller, Catarina Fernandes, PhD, Martina Fontana, Tatiana Remenova, Stefan Söderberg and Tobias J Lange. #connectivetissuedisease #CTD #pulmonaryhypertension #pulmonaryarterialhypertension #PAH #chronicthromboembolicpulmonaryhypertension #CTEPH #knowledgesharing #knowledgeexchange #patientempowerment #patienteducation #allianceforph #organtransplant #organdonation #transplant #lungtransplant HTaPFrance Stichting Pulmonale Hypertensie / PH Association the Netherlands PH Belgium - Pulmonale Hypertensie vzw AIPI Italian Pulmonary Hypertension Association Pulmoner Hipertansiyon ve Skleroderma Hasta Dernegi Hellenic Community for Pulmonary Hypertension Pulmonale Hypertonie E.V. Ieva Plume PHA Polska PHA Japan https://lnkd.in/d2mgBA38

"*Blood in urine* (known as *hematuria*) is an important finding in a urine sample that can indicate a variety of underlying health issues. The presence of blood in the urine can range from microscopic (not visible to the naked eye) to gross (visible as a red or pink discoloration of the urine). Hematuria can be caused by many factors, including *urinary tract infections (UTIs)*, *kidney stones*, *bladder or kidney infections*, *trauma*, or more serious conditions like *bladder cancer* or *kidney disease*. It's crucial to investigate the cause of blood in the urine through additional tests, such as *urinalysis*, *ultrasound*, or *CT scans*, to determine the exact source and appropriate treatment. If you notice blood in your urine or are advised to undergo a test that shows hematuria, it’s important not to ignore it. Early detection and treatment of the underlying cause can help prevent complications and ensure better health outcomes. #BloodInUrine #Hematuria #UrinaryTractInfection #KidneyStones #BladderHealth #UrineAnalysis #HealthAwareness #MedicalTesting #KidneyCare"